These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36639062)

  • 21. A novel cognitive assessment paradigm to detect Pre-mild cognitive impairment (PreMCI) and the relationship to biological markers of Alzheimer's disease.
    Crocco EA; Loewenstein DA; Curiel RE; Alperin N; Czaja SJ; Harvey PD; Sun X; Lenchus J; Raffo A; Peñate A; Melo J; Sang L; Valdivia R; Cardenas K
    J Psychiatr Res; 2018 Jan; 96():33-38. PubMed ID: 28957712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelin content changes in probable Alzheimer's disease and mild cognitive impairment: Associations with age and severity of neuropsychiatric impairment.
    Kavroulakis E; Simos PG; Kalaitzakis G; Maris TG; Karageorgou D; Zaganas I; Panagiotakis S; Basta M; Vgontzas A; Papadaki E
    J Magn Reson Imaging; 2018 May; 47(5):1359-1372. PubMed ID: 28861929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Arlt S; Buchert R; Spies L; Eichenlaub M; Lehmbeck JT; Jahn H
    Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):335-44. PubMed ID: 22940716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.
    Inui Y; Ito K; Kato T;
    J Alzheimers Dis; 2017; 60(3):877-887. PubMed ID: 28922157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline.
    Thomas KR; Osuna JR; Weigand AJ; Edmonds EC; Clark AL; Holmqvist S; Cota IH; Wierenga CE; Bondi MW; Bangen KJ;
    J Cereb Blood Flow Metab; 2021 May; 41(5):1001-1012. PubMed ID: 32615887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resting state functional connectivity abnormalities and delayed recall performance in patients with amnestic mild cognitive impairment.
    Joshi H; Bharath S; John JP; Sadanand S; Saini J; Kumar K; Varghese M
    Brain Imaging Behav; 2020 Feb; 14(1):267-277. PubMed ID: 30421086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Brief Version of the LASSI-L Detects Prodromal Alzheimer's Disease States.
    Crocco E; Curiel-Cid RE; Kitaigorodsky M; González-Jiménez CJ; Zheng D; Duara R; Loewenstein DA
    J Alzheimers Dis; 2020; 78(2):789-799. PubMed ID: 33074233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rey's Auditory Verbal Learning Test scores can be predicted from whole brain MRI in Alzheimer's disease.
    Moradi E; Hallikainen I; Hänninen T; Tohka J;
    Neuroimage Clin; 2017; 13():415-427. PubMed ID: 28116234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Volumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease.
    Shen Q; Loewenstein DA; Potter E; Zhao W; Appel J; Greig MT; Raj A; Acevedo A; Schofield E; Barker W; Wu Y; Potter H; Duara R
    Alzheimers Dement; 2011 Jul; 7(4):e101-8. PubMed ID: 21784342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Saccade deficits in amnestic mild cognitive impairment resemble mild Alzheimer's disease.
    Peltsch A; Hemraj A; Garcia A; Munoz DP
    Eur J Neurosci; 2014 Jun; 39(11):2000-13. PubMed ID: 24890471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
    Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
    Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain
    Mitolo M; Stanzani-Maserati M; Capellari S; Testa C; Rucci P; Poda R; Oppi F; Gallassi R; Sambati L; Rizzo G; Parchi P; Evangelisti S; Talozzi L; Tonon C; Lodi R; Liguori R
    Neuroimage Clin; 2019; 23():101843. PubMed ID: 31071594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in LASSI-L performance over time among older adults with amnestic MCI and amyloid positivity: A preliminary study.
    Kitaigorodsky M; Curiel Cid RE; Crocco E; Gorman KL; González-Jiménez CJ; Greig-Custo M; Barker WW; Duara R; Loewenstein DA
    J Psychiatr Res; 2021 Nov; 143():98-105. PubMed ID: 34464879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the Profile of Incidental Memory in Patients with Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Kontaxopoulou D; Beratis IN; Fragkiadaki S; Pavlou D; Andronas N; Yannis G; Economou A; Papanicolaou AC; Papageorgiou SG
    J Alzheimers Dis; 2018; 65(2):617-627. PubMed ID: 30056423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
    Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer's disease subgroups.
    Groot C; Grothe MJ; Mukherjee S; Jelistratova I; Jansen I; van Loenhoud AC; Risacher SL; Saykin AJ; Mac Donald CL; Mez J; Trittschuh EH; Gryglewski G; Lanzenberger R; Pijnenburg YAL; Barkhof F; Scheltens P; van der Flier WM; Crane PK; Ossenkoppele R
    Neuroimage Clin; 2021; 30():102660. PubMed ID: 33895633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.